Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin. [electronic resource]
Producer: 20010111Description: 2129-33 p. digitalISSN:- 0022-5347
- Administration, Intravesical
- Aged
- Aged, 80 and over
- BCG Vaccine -- therapeutic use
- Carcinoma, Transitional Cell -- diagnosis
- Enzyme-Linked Immunosorbent Assay
- Female
- Follow-Up Studies
- Humans
- Immunotherapy
- Interleukin-18 -- urine
- Interleukin-8 -- urine
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- diagnosis
- Predictive Value of Tests
- Sensitivity and Specificity
- Treatment Outcome
- Urinary Bladder Neoplasms -- diagnosis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.